0 NASDAQ Companies - July 1, 2019Axsome Therapeutics Added to Russell 3000® and Russell 2000® IndexesRead More
0 NASDAQ Companies - July 1, 2019Axovant Appoints David Nassif as Chief Financial Officer and Expands Board of DirectorsRead More
0 NASDAQ Companies - July 1, 2019Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics Shareholders Vote “FOR” ALL of Progenics’ Director NomineesRead More
0 NASDAQ Companies - July 1, 2019Uniti Group Inc. Comments on UMB and U.S. Bank Filing in Windstream’s Bankruptcy CaseRead More
0 NASDAQ Companies - July 1, 2019Quotient Limited Announces the Submission of the Initial SDS Microarray CE mark Filing for MosaiQ™Read More
0 NASDAQ Companies - July 1, 2019Victory Capital Completes Acquisition of USAA® Asset Management CompanyRead More
0 NASDAQ Companies - July 1, 2019Agios Announces Orlando Oliveira Appointed as Senior Vice President and General Manager, InternationalRead More
0 NASDAQ Companies - July 1, 2019Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing CollaborationRead More
0 NASDAQ Companies - July 1, 2019EyePoint Pharmaceuticals Added to Russell 3000® and 2000® IndexesRead More
0 NYSE Companies - July 1, 2019Genesee & Wyoming Inc. to be Acquired by Brookfield Infrastructure and GIC in $8.4 Billion Transaction Read More
